Skip to main content
Erschienen in: Urologie in der Praxis 3/2019

23.08.2019 | Originalien

Operative Therapie der Prostatahyperplasie

verfasst von: Gallus Beatus Ineichen, Hansjörg Danuser

Erschienen in: Urologie in der Praxis | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die apparativen Therapiemöglichkeiten zur Verbesserung der Miktionssituation wegen Prostataobstruktionssymptomen sind vielseitig und können immer besser dem individuellen Patienten angepasst werden. Die Standardtherapie bleibt die TUR‑P (transurethrale Resektion der Prostata). Die Erfahrung zeigt, dass mehr Therapiemöglichkeiten auf den Markt kommen, als sich durchsetzen können. Nicht zuletzt aus ökonomischen Überlegungen kann nicht jede Klinik alle Therapiemöglichkeiten vorhalten. Trotzdem kann insbesondere älteren und fragileren Patienten neben der medikamentösen Behandlung auch eine desobstruierende operative Therapie angeboten werden.
Literatur
1.
Zurück zum Zitat Ahyai SA, Gilling P, Kaplan SA et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397CrossRef Ahyai SA, Gilling P, Kaplan SA et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397CrossRef
2.
Zurück zum Zitat Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol 174:1887–1891CrossRef Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol 174:1887–1891CrossRef
4.
Zurück zum Zitat Issa MM (2008) Technological advances in transurethral resection of the prostate: bipolar vs monopolar TURP. J Endourol 22:1587–1595CrossRef Issa MM (2008) Technological advances in transurethral resection of the prostate: bipolar vs monopolar TURP. J Endourol 22:1587–1595CrossRef
5.
Zurück zum Zitat Akman T, Binbay M, Tekinarslan E, Tepeler A, Akcay M, Ozgor F, Ugurlu M, Muslumanoglu A (2013) Outcomes of bipolar vs monopolar TURP. BJU Int 111:129–136CrossRef Akman T, Binbay M, Tekinarslan E, Tepeler A, Akcay M, Ozgor F, Ugurlu M, Muslumanoglu A (2013) Outcomes of bipolar vs monopolar TURP. BJU Int 111:129–136CrossRef
7.
Zurück zum Zitat Danuser H (2019) Die transurethrale Prostataresektion bei Patienten unter Blutverdünnung. Lead Opin Urol 9(1):11–12 Danuser H (2019) Die transurethrale Prostataresektion bei Patienten unter Blutverdünnung. Lead Opin Urol 9(1):11–12
8.
Zurück zum Zitat Wroclawski ML, Carneiro A, Amarante RD et al (2016) ‘Button type’ bipolar plasma vaporisation of the prostate compared with standard transurethral resection: a systematic review and meta-analysis of short-term outcome studies. BJU Int 117:662–668CrossRef Wroclawski ML, Carneiro A, Amarante RD et al (2016) ‘Button type’ bipolar plasma vaporisation of the prostate compared with standard transurethral resection: a systematic review and meta-analysis of short-term outcome studies. BJU Int 117:662–668CrossRef
9.
Zurück zum Zitat Reich O, Gratzke C, Stief CG (2006) Techniques and long-term results of surgical procedures for BPH. Eur Urol 49:970–978CrossRef Reich O, Gratzke C, Stief CG (2006) Techniques and long-term results of surgical procedures for BPH. Eur Urol 49:970–978CrossRef
11.
Zurück zum Zitat Sorokin I et al (2017) Robot-assisted versus open simple prostatectomy for benign prostatic Hyperplasia in large glands: a propensity score-matched comparison of Perioperative and short-term outcomes. J Endourol 31:1164–1169CrossRef Sorokin I et al (2017) Robot-assisted versus open simple prostatectomy for benign prostatic Hyperplasia in large glands: a propensity score-matched comparison of Perioperative and short-term outcomes. J Endourol 31:1164–1169CrossRef
13.
Zurück zum Zitat Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G, N’Dow J; Benign Prostatic Enlargement team (2008) Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ 337:a449CrossRef Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G, N’Dow J; Benign Prostatic Enlargement team (2008) Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ 337:a449CrossRef
16.
Zurück zum Zitat Thomas JA et al (2016) A Multicenter randomized Noninferiority trial comparing greenlight-XPS laser vaporization of the prostate and Transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol 69:94–102CrossRef Thomas JA et al (2016) A Multicenter randomized Noninferiority trial comparing greenlight-XPS laser vaporization of the prostate and Transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol 69:94–102CrossRef
17.
Zurück zum Zitat Rosario DJ, Phillips JT, Chapple CR (2007) Durability and cost-effectiveness of Transurethral needle ablation of the prostate as an alternative to Transurethral resection of the prostate when α‑Adrenergic antagonist therapy fails. J Urol 177:1047–1051CrossRef Rosario DJ, Phillips JT, Chapple CR (2007) Durability and cost-effectiveness of Transurethral needle ablation of the prostate as an alternative to Transurethral resection of the prostate when α‑Adrenergic antagonist therapy fails. J Urol 177:1047–1051CrossRef
18.
Zurück zum Zitat Corica AP, Larson BT, Sagaz A, Corica AG, Larson TR (2004) A novel temporary prostatic stent for the relief of prostatic urethral obstruction. BJU Int 93:346–348CrossRef Corica AP, Larson BT, Sagaz A, Corica AG, Larson TR (2004) A novel temporary prostatic stent for the relief of prostatic urethral obstruction. BJU Int 93:346–348CrossRef
19.
Zurück zum Zitat Roehrborn CG et al (2013) The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol 190:2161–2167CrossRef Roehrborn CG et al (2013) The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol 190:2161–2167CrossRef
20.
Zurück zum Zitat Porpiglia F et al (2015) Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up. BJU Int 116:278–287CrossRef Porpiglia F et al (2015) Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up. BJU Int 116:278–287CrossRef
21.
Zurück zum Zitat Gilling P, Barber N, Bidair M et al (2018) WATER: a double-blind, randomized, controlled trial of Aquablation vs Transurethral resection of the prostate in benign prostatic Hyperplasia. J Urol 199:1252–1261CrossRef Gilling P, Barber N, Bidair M et al (2018) WATER: a double-blind, randomized, controlled trial of Aquablation vs Transurethral resection of the prostate in benign prostatic Hyperplasia. J Urol 199:1252–1261CrossRef
22.
Zurück zum Zitat Roehrborn CG et al (2017) Convective thermal therapy: durable 2‑year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic Hyperplasia. J Urol 197:1507–1516CrossRef Roehrborn CG et al (2017) Convective thermal therapy: durable 2‑year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic Hyperplasia. J Urol 197:1507–1516CrossRef
23.
Zurück zum Zitat Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kessler TM et al (2018) Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label,non-inferiority trial. BMJ 361:k2338CrossRef Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kessler TM et al (2018) Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label,non-inferiority trial. BMJ 361:k2338CrossRef
Metadaten
Titel
Operative Therapie der Prostatahyperplasie
verfasst von
Gallus Beatus Ineichen
Hansjörg Danuser
Publikationsdatum
23.08.2019
Verlag
Springer Vienna
Erschienen in
Urologie in der Praxis / Ausgabe 3/2019
Print ISSN: 2661-8737
Elektronische ISSN: 2661-8745
DOI
https://doi.org/10.1007/s41973-019-00066-x

Weitere Artikel der Ausgabe 3/2019

Urologie in der Praxis 3/2019 Zur Ausgabe

News-Screen Urologie

News-Screen Urologie

Éditorial

Éditorial